0001104659-23-112611.txt : 20231030 0001104659-23-112611.hdr.sgml : 20231030 20231030164853 ACCESSION NUMBER: 0001104659-23-112611 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231030 DATE AS OF CHANGE: 20231030 EFFECTIVENESS DATE: 20231030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RiverVest Venture Management LLC CENTRAL INDEX KEY: 0001812549 IRS NUMBER: 431900629 STATE OF INCORPORATION: MO FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-21321 FILM NUMBER: 231360975 BUSINESS ADDRESS: STREET 1: 101 S. HANLEY ROAD STREET 2: SUITE 1850 CITY: ST. LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 314-726-6700 MAIL ADDRESS: STREET 1: 101 S. HANLEY ROAD STREET 2: SUITE 1850 CITY: ST. LOUIS STATE: MO ZIP: 63105 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001812549 XXXXXXXX 09-30-2023 09-30-2023 false RiverVest Venture Management LLC
101 S. Hanley Road Suite 1850 St. Louis MO 63105
13F HOLDINGS REPORT 028-21321 N
Sivan Weitzman Chief Financial Officer 314-726-6700 /s/ Sivan Weitzman St. Louis MO 10-30-2023 0 5 40430168
INFORMATION TABLE 2 infotable.xml Allakos, Inc. Common 01671P100 11321675 4987522 SH OTR 3349223 1638299 0 Spruce Bioscience, Inc. Common 85209E109 6635996 2936281 SH SOLE 2936281 0 0 Vapotherm, Inc. Common 922107107 132965 52552 SH OTR 0 52552 0 Reneo Pharmaceuticals, Inc. Common 75974E103 19298085 2534220 SH SOLE 2534220 0 0 Xilio Therapeutics, Inc. Common 98422T100 3041447 1441444 SH SOLE 1441444 0 0